Excellent point and I was thinking about this yesterday.....
Anybody, including say Johnson&Johnson, who gets on the front foot with partnering or buying The DurAVR TAVR technology will also implicitly be the frontrunner to buy or partner the v2v mitral valve repair technology..... very smart move by Wayne Paterson and the team.
- Forums
- ASX - By Stock
- AVR
- Johnson & Johnson Action
AVR
anteris technologies global corp.
Add to My Watchlist
2.07%
!
$6.14

Johnson & Johnson Action, page-13
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$6.14 |
Change
-0.130(2.07%) |
Mkt cap ! $95.16M |
Open | High | Low | Value | Volume |
$6.20 | $6.30 | $6.12 | $4.935K | 797 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3431 | $6.15 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.30 | 539 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3431 | 6.150 |
2 | 3639 | 6.120 |
1 | 2000 | 6.100 |
1 | 1250 | 5.950 |
1 | 857 | 5.830 |
Price($) | Vol. | No. |
---|---|---|
6.300 | 539 | 2 |
6.400 | 450 | 2 |
6.500 | 255 | 1 |
6.550 | 1092 | 1 |
6.650 | 242 | 2 |
Last trade - 15.47pm 30/06/2025 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |